Global H2 2015 Peripheral Neuropathic Pain Pipeline Review - Research and Markets

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/xttzk2/peripheral) has announced the addition of the "Peripheral Neuropathic Pain - Pipeline Review, H2 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Peripheral Neuropathic Pain, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Peripheral Neuropathic Pain and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Peripheral Neuropathic Pain Overview
  3. Therapeutics Development
  4. Pipeline Products for Peripheral Neuropathic Pain - Overview
  5. Pipeline Products for Peripheral Neuropathic Pain - Comparative Analysis
  6. Peripheral Neuropathic Pain - Therapeutics under Development by Companies
  7. Peripheral Neuropathic Pain - Therapeutics under Investigation by Universities/Institutes
  8. Peripheral Neuropathic Pain - Pipeline Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Peripheral Neuropathic Pain - Products under Development by Companies
  13. Peripheral Neuropathic Pain - Products under Investigation by Universities/Institutes
  14. Peripheral Neuropathic Pain - Companies Involved in Therapeutics Development
  • AnaBios Corporation
  • Astellas Pharma Inc.
  • Eli Lilly and Company
  • GW Pharmaceuticals Plc
  • Nektar Therapeutics
  • Phosphagenics Limited
  • Sunovion Pharmaceuticals Inc.
  • Zynerba Pharmaceuticals, Inc.

For more information visit http://www.researchandmarkets.com/research/xttzk2/peripheral

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Central Nervous System

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Central Nervous System